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axillobifemoral bypass grafting in marginal risk patients
have been the traditional treatments for patients with
extensive bilateral iliac occlusive disease.8 Several series
have reported on the use of FFB grafts in patients with
bilateral iliac occlusive disease in whom the donor iliac
artery is treated with transluminal balloon angioplasty.9-16
Iliac balloon angioplasty (IBA) on the donor side of the
FFB graft is often used in conjunction with bypass graft-
ing to augment flow to the donor femoral vessel. The
combined procedure offers the advantage of improving
both inflow and outflow in patients with significant
comorbidities that preclude aortobifemoral bypass graft-
ing. However, the durability of FFB/IBA procedures has
proved to be diminished in some patients, often requiring
revision to an aortobifemoral bypass grafting, thus,
increasing operative risk. Ideally, if those individuals who
are at high risk for early graft failure could be identified
before operation, then the patient could undergo one pro-
cedure or the other and avoid the risk of two bypass oper-
ations. This study examines the selection of patients for
The success of femorofemoral bypass (FFB) grafting in
restoring flow to a lower extremity that is affected by uni-
lateral iliac stenosis is well established.1-4 Since its first
introduction by Dotter and Judkins5 in 1964, percuta-
neous transluminal angioplasty (PTA) has become the
treatment of choice for localized iliac artery stenosis.5-7
Aortobifemoral bypass grafting in good risk patients or
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Purpose: This study examines the selection of patients for combined femorofemoral bypass (FFB) grafting and iliac balloon
angioplasty (IBA) and stenting for bilateral iliac occlusive disease (successively or simultaneously) and the correlation of the
length and location of stenoses of the donor iliac artery to the success of FFB grafts.
Methods: Forty-one patients with long iliac occlusion and significant contralateral iliac stenosis were treated with combined
FFB grafting and IBA and stenting, which were performed simultaneously or percutaneously within 1 to 2 days before
surgery. Stenting was performed for suboptimal IBAs. IBA/graft patency was evaluated by duplex scanning/ankle-brachial
index at 1, 3, 6, and 12 months and every 12 months thereafter. A life-table analysis of patency was performed, according to
the length of stenosis as classified by the Society of Cardiovascular Interventional Radiology (group A, <3 cm and 3-5 cm;
group B, >5 cm).
Results: Indications for surgery were limb salvage (22%), rest pain (44%), and claudication (34%). The mean follow-up time
was 34.1 months. Perioperative complications were 7% for group A versus 62% for group B (P = .0007) with no periopera-
tive deaths or amputations. Stenting was needed in 12 of 13 patients (92%) in group B versus four of 28 patients (14%) in
group A (P < .0001) and in 11 of 12 external iliac artery lesions versus five of 29 common iliac artery lesions (P < .0001).
The overall early success rate was 100% for group A and 62% for group B (P = .0028). The primary patency rates at 1, 2, and
3 years were 96%, 85%, and 85% for group A, respectively, and for group B were 46%, 46%, and 31%, respectively (P < .01).
The secondary patency rates for group A at 1, 2, and 3 years were 100%, 96%, and 87%, respectively; and for group B were
62%, 54%, and 27%, respectively (P < .001). The overall primary and secondary patency rates for common iliac and external
iliac artery lesions were similar (72% and 72% versus 67% and 75%, respectively). The overall limb salvage rates were 96% for
group A and 85% for group B. Seven of 13 patients (54%) of group B, in contrast with 0 of 28 patients in group A, had to
undergo a revision of the procedure within 30 days (P < .01).
Conclusion: Combined use of IBA and stenting and FFB grafting is effective and durable and can be performed simultane-
ously, if the donor iliac stenosis length is 5 cm or less. Percutaneous transluminal angioplasty/stenting of stenoses of 5 cm or
more fail to support FFB grafting in most patients; therefore, their combination should be questioned. (J Vasc Surg
2001;33:S93-9.)
combined FFB grafting and IBA and stenting for bilateral
iliac occlusive disease (successively or simultaneously) and
the correlation of the length and location of stenoses of
the donor iliac artery to the success of the FFB graft.
PATIENT POPULATION AND METHODS 
The medical records of 41 patients with long iliac arte-
rial occlusion and significant contralateral iliac stenoses
who were treated with a combined FFB graft and IBA
with or without stenting during a 5-year period were ana-
lyzed. The IBA was performed simultaneously or percuta-
neously within 1 to 2 days before surgery. The study
population was divided into three groups, according to
the length of the donor iliac artery stenosis as classified by
the Society of Cardiovascular Interventional Radiology:
group A, 3 cm or less and 3 to 5 cm; group B, more than
5 cm. Stenoses were also classified according to location
(ie, common iliac artery versus external iliac artery). The
preoperative evaluation included a clinical vascular exami-
nation, preoperative segmental Doppler pressures with
measurement of the ankle-brachial index, and arteriogra-
phy visualization of the abdominal aorta and arteries of
both lower extremities. All demographic and clinical char-
acteristics were collected and analyzed.
Procedures. All patients were treated in the operating
room, and both the FFB grafting and the donor IBA
and/or stenting were performed simultaneously by the
senior vascular surgeon (A.F.A.), except for 12 patients
who underwent percutaneous IBA within 1 to 2 days
before the FFB grafting. The operative procedures were
performed with the use of regional anesthesia (epidural or
spinal) and 8-mm ringed Goretex vascular grafts (W. L.
Gore & Associates, Inc, Flagstaff, Ariz). An operating
room equipped with a digital fluoroscopy unit (Fluro Plus;
Phillips Medical Systems, Denver, Colo) was used during
the first half of the study, and a special vascular suite that
was equipped with an ISS system (International Surgical
System, Phoenix, Ariz) was used in the second half of the
study. IBA was performed with the use of low-profile
Meditech ultra-thin balloon catheters (Boston Scientific,
Watertown, Mass) in 2 to 4 cm lengths, 7 to 12 mm in
diameter, according to the length of the lesion and the size
of the artery as measured by intraoperative arteriograms.
The balloons were dilated to a pressure of 8 to 12 atm for
1 to 2 minutes. After IBA, pressure gradients (proximal
and distal to the iliac lesion) were measured, and brachial
and femoral arterial pressures were compared to assess
hemodynamic success. Stenting was performed for subop-
timal IBAs, as manifested by a pressure gradient of more
than 10 mm Hg, gross long dissection, or residual steno-
sis (>30% reduction in luminal diameter). Twelve of 13
iliac arteries in group B were stented (wall stents
[Schneider; Boston Scientific] in nine lesions, one stent
each in six lesions, and two stents in three lesions; three
lesions had two Palmaz stents [Cordis; J & J, Warren, NJ]
each). Four lesions in group A were stented (one Palmaz
stent each). The IBAs, with or without stenting, were con-
sidered an early success when there was no residual steno-
sis as defined radiologically (<30% luminal narrowing) and
hemodynamically (when the pressure gradient was abol-
ished or decreased to less than 10 mm Hg).
All patients received antiplatelet therapy (325 mg
aspirin daily) within 24 hours after operation, and patients
with stenting received both 325 mg aspirin daily and clopi-
dogrel bisulfate (Plavix; 300 mg by mouth the first day after
operation and then 75 mg by mouth daily) for 6 weeks.
Postoperative surveillance. Follow-up consisted of
clinical examinations supplemented with duplex examina-
tions and ankle-brachial index measurements at 1, 3, 6,
and 12 months and every 12 months thereafter. Every
effort was made to comply with the reporting standards
for lower extremity endovascular procedures as advocated
by the Ad Hoc Committee of the Joint Council of the
Society of Vascular Surgery/North American Chapter of
the International Society of Cardiovascular Surgery.17
Perioperative morbidity and mortality rates were defined
as events occurring within 30 days after operation. Graft
patency was assessed by duplex examination, and the clin-
ical and hemodynamic improvements were judged by the
clinical examination and the ankle-brachial indexes.
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Table I. Demographic and clinical characteristics
Group A Group B P
(28 patients) (13 patients) value
Mean age (y) 72.6 68.5 NS
Smoking (n;%) 18 (64) 10 (77) NS
Diabetes mellitus (n;%) 8 (29) 5 (39) NS
Hypertension (n;%) 20 (71) 6 (46) NS
Hypercholesterolemia (n;%) 11 (39) 7 (54) NS
Coronary artery disease (n;%) 17 (61) 8 (62) NS
Preoperative ABI: donor leg (mean) 0.51 0.43 NS
Preoperative ABI: recipient leg (mean) 0.49 0.44 NS
PTA (n;%) 8 (29) 4 (31) NS
Open PTA (n;%) 20 (71) 9 (69) NS
NS, Not significant; ABI, ankle-brachial index.
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Arteriograms were obtained when new symptoms
developed, a 15% drop in the ankle-brachial index was
detected, or a duplex examination documented >50%
stenosis or occlusion of the graft or IBA.
Statistical analysis. The differences between groups
A and B and the common iliac artery and external iliac
artery lesions were assessed with the use of the chi-squared
analysis and 2-tailed t test. Primary and secondary graft
patency was evaluated with the life-table method. The
cumulative success rates for both groups were then com-
pared with the use of the log-rank test. 
RESULTS
The indications for surgery were limb salvage in nine
patients (22%), rest pain in 18 patients (44%), and dis-
abling claudication in 14 patients (34%). The mean fol-
low-up was 34.1 months, with a range of 1 to 66 months.
Table I summarizes the demographic and clinical charac-
teristics. As noted, there were no statistically significant
differences between groups A and B. Overall, there were
28 patients in group A; nine patients had less than 3-cm
donor iliac stenosis, and 19 patients had 3- to 5-cm iliac
stenoses. There were 13 patients in group B, all of whom
had more than 5- to 10-cm donor iliac stenoses.
Tables II and III summarize the location of the donor
iliac artery stenosis and the status of the superficial femoral
arteries. The condition of four of the 28 patients in group
A required stenting, in contrast with the condition of 12
of 13 patients in group B (P < .0001). Eleven of 12 exter-
nal iliac artery lesions required stenting, in contrast with
five of 29 for common iliac artery lesions that required
stenting (P < .0001). Indications for stenting in group A
included two patients with a pressure gradient of more
than 10 mm Hg and two other patients with a pressure
gradient with gross dissection. The indications for stenting
in group B were a pressure gradient of more than 10 mm
Hg in five patients and a pressure gradient and gross dis-
section in seven patients.
The mean preoperative ankle-brachial index of the
donor iliac arteries in groups A and B were similar: 0.51
(range, 0.32-0.8) and 0.43 (range, 0.3-0.53), respectively.
Similarly, the mean preoperative ankle-brachial index of
the recipient limb was also similar in both groups (0.49
[range, 0.32-0.73] versus 0.44 [range, 0.32-0.56], respec-
tively). However, the mean postoperative ankle-brachial
index of the donor iliac artery was significantly better in
group A than in group B (0.73 [range, 0.55-0.96] versus
0.57 [range, 0.36-0.9], respectively). Similarly, the mean
postoperative ankle-brachial index of the recipient limb in
group A was higher than in group B (0.72 [range, 0.56-
0.91] versus 0.56 [range, 0.44-0.80], respectively).
Group A had a statistically significantly better early
success rate (100%) than group B (8/13 patients; 62%; P
= .003). The 30-day perioperative complication rate in
group A was 7% (2/28 patients) and 62% (8/13 patients)
in group B (P = .0007). There were two complications in
group A: one patient with postoperative deep vein throm-
bosis and one patient with bleeding that necessitated oper-
ative intervention with an uneventful recovery. In
contrast, there were eight perioperative complications in
group B that consisted of one patient with a superficial
wound infection that was treated with antibiotics with an
uneventful recovery and seven patients with perioperative
graft thrombosis. Two of these seven patients had throm-
bosis of the graft and IBA site (one patient at 2 weeks and
one patient at 3 weeks after operation); one patient was
treated by thrombectomy successfully, and one patient
underwent a successful thrombectomy and new IBA and
stenting. Five other patients had early thrombosis (before
discharge from initial IBA and bypass grafting) of their
graft and IBA site (two patients within 24 hours, one
patient in 48 hours, one patient at 72 hours, and one
patient at 1 week). All of these underwent a thrombec-
tomy that failed because of failed donor IBA. Four of
these patients underwent axillobifemoral bypass grafts
(three of which were performed in the same setting as the
thrombectomy), and one patient underwent aorto-
bifemoral bypass grafting. Overall, seven of 13 patients
(54%) in group B, in contrast with 0 of 28 patients in
group A, had to undergo a revision of the procedure
within 30 days (P < .01).
There were no perioperative deaths or amputations in
either group. There were three late deaths in group A and
one late death in Group B, all of which were related to
myocardial infarction, except for one patient in group A
who died from malignancy.
Table II. Location of donor iliac stenosis
Group A Group B TOTAL
Site (n) (n) (n)
Common iliac artery (%) 23 (82) 6 (46) 29 (71)
External iliac artery (%) 4 (14) 3 (23) 7 (17)
Common and external  (%) 1 (4)* 4 (31)* 5 (12)
iliac arteries
TOTAL 28 13 41
*P = .0246.
Table III. Status of superficial femoral artery (SFA)
Status Group A* Group B* TOTAL
(n) (n) (n)
No SFA occlusion (%) 16 (57) 5 (39) 21 (51)
Left SFA occlusion (%) 6 (21) 2 (15) 8 (20)
Right SFA occlusion (%) 1 (4) 3 (23) 4 (10)
Bilateral SFA occlusion (%) 5 (18) 3 (23) 8 (20)
TOTAL 28 13 41
*P = .2254.
The limb salvage rates for groups A and B were 96%
(27/28 patients) and 85% (11/13 patients), respectively.
Graft patency/location and length of donor iliac
stenosis. The overall primary and secondary patency rates
for common iliac and external iliac artery lesions were sim-
ilar (72% and 72% versus 67% and 75%; P = .828 and P =
.992, respectively; Table IV). However, 11 of 12 external
iliac artery lesions needed stenting versus five of 29 com-
mon iliac artery lesions. Four of 29 common iliac artery
lesions failed immediately (after PTA and stenting) versus
three of 12 external iliac artery lesions (14% versus 25%;
NS). For external iliac artery lesions, four of seven lesions
of more than 5 cm failed versus 0 of five lesions that were
5 cm or less (57% versus 0%; P = .117). For common iliac
artery lesions, four of six lesions for more than 5 cm failed
versus four of 23 lesions that were 5 cm or less (67% ver-
sus 17%; P = .055).
Table V (Fig 1) and Table VI (Fig 2) show the Kaplan-
Meier life-table analysis for primary and secondary patency
for groups A and B, respectively. The primary patency rate
at 1, 2, and 3 years were 96%, 85%, and 85%, respectively,
for group A and 46%, 46%, and 31%, respectively, for
group B (P < .01; Table V, Fig 1). The secondary patency
rates at 1, 2, and 3 years were 100%, 96%, and 87%,
respectively, for group A and 62%, 54%, and 27%, respec-
tively, for group B (P < .001; Table VI, Fig 2). 
DISCUSSION
Extra-anatomic revascularization of the lower extrem-
ities has been incorporated into the vascular surgeon’s
armamentarium as an effective means to restore flow to
the lower extremities and supplant the untoward effects of
major abdominal surgery, as in aortobifemoral bypass
grafting.
Vetto1 first described FFB grafting for the treatment of
unilateral iliac artery obstruction in 1962. Since that time,
this procedure has been used extensively for unilateral iliac
disease in patients deemed at high risk for abdominal aor-
tic reconstruction. Several reports have documented 5-year
primary patency rates for FFB grafting that range from 55%
to 92%, with an operative mortality rate that ranges from
0% to 6.2%.18-24 With these good results, indications for
crossover FFB grafting were broadened; therefore, it is
becoming an accepted procedure for the treatment of
severe unilateral iliac artery occlusive disease in both good-
risk and high-risk patients.
IBA has been proved to be safe and effective for focal
iliac artery stenoses. In a meta-analysis of 2697 patients
with IBAs, the initial success rate was 92%, and the 5-year
patency rate was 72%.25 In addition, the placement of
stents may improve the long-term results after IBA. In a
multicenter trial of nearly 600 patients with IBAs with pri-
mary stenting, Palmaz et al26 reported a clinical success
rate of 86.6% at 43 months. Tetteroo et al,27 in a prospec-
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Fig 1. Kaplan-Meier life table analysis shows time to loss of primary patency (group A lesions of 5 cm or less and group B lesions of
more than 5 cm).
Table IV. Location of donor iliac stenosis/patency
Common iliac* External iliac *
artery (n) artery (n)
Primary patency*
Patent (%) 21 (72) 8 (67)
Not patent (%) 8 (28) 4 (33)
TOTAL 29 12
Secondary patency†
Patent(%) 21 (72) 9 (75)




JOURNAL OF VASCULAR SURGERY
Volume 33, Number 2 AbuRahma et al S97
tive randomized study that compared systematic primary
stenting with selective stent placement, found no statisti-
cally significant differences and favored selective stenting.
Stenting in our series was only used selectively in patients
with suboptimal IBA results (ie, the presence of significant
pressure gradient or gross long dissection). This was noted
more often in group B patients (long lesion, >5-10 cm).
With the advancement of endoluminal angioplasty, the
utility of FFB grafting became extended for use with bilat-
eral iliac disease in which the occlusion of the proposed
donor iliac artery was focal and amenable to angioplasty.
Porter et al9 described the first report of the combined
procedure for limb salvage in 1973. Since that time, oth-
ers have described the two procedures performed either
simultaneously or in succession.10-16,24 Much of this
reported experience is anecdotal, with no patency data
Fig 2. Kaplan-Meier life table analysis shows time to loss of secondary patency (group A lesions of 5 cm or less and group B lesions of
more than 5 cm).
Table V. Kaplan-Meier life table analysis of time to loss of primary patency
Time At risk at start Treatment Withdrawn Interval Cumulative SE
interval (mo) of interval failure (n) (n) success success (%) (%)
Group A
0 28 0 0 1 100.00 0.00
1 28 0 0 1 100.00 0.00
12 28 1 1 0.964286 96.43 3.44
18 26 1 0 0.961538 92.72 4.91
24 25 2 3 0.92 85.30 6.54
30 20 0 3 1 85.30 7.31
36 17 0 4 1 85.30 7.93
42 13 0 2 1 85.30 9.07
48 11 0 1 1 85.30 9.86
54 10 0 4 1 85.30 10.34
60 6 0 2 1 85.30 13.35
66 4 0 4 1 85.30 16.35
Group B
0 13 0 0 1 100.00 0.00
1 13 7 0 0.461538 46.15 9.39
12 6 0 0 1 46.15 13.83
18 6 0 2 1 46.15 13.83
24 4 0 1 1 46.15 16.93
30 3 1 1 0.666667 30.77 14.78
36 1 0 1 1 30.77 25.60
42 0 0 0
48 0 0 0
54 0 0 0
60 0 0 0
66 0 0 0
being reported in some series and limited long-term fol-
low-up in others. Only three previous reports with a good
number of patients (20, 24, and 26 patients) included in
the series have actually documented primary graft patency
rates.15,22,24 Peterkin et al24 reported a 5-year primary
patency rate of 83% among 20 patients who underwent
FFB grafting and donor IBA. Criado et al22 reported a 1-
year primary graft patency rate of 78% among 24 patients
who had IBAs of the donor iliac artery, as opposed to a
patency rate of 91% in patients who did not undergo IBA.
Perler and Williams15 reported a 5-year primary graft
patency rate of 79% in 26 patients who underwent FFB
grafting with IBA of the donor iliac artery. The primary
patency rates of 41 patients in our series at 1, 2, and 3
years were 96%, 85%, and 85%, respectively, for patients
with an FFB graft and an IBA of the donor iliac artery
with a lesion of 5 cm or less.
Although the number of patients in our series is too
small to allow for a meaningful subset analysis, external iliac
artery lesions had a comparable outcome to common iliac
artery lesions if the length of the stenosis was similar. In
contrast, Johnston28 reported that PTA of external iliac
artery lesions was inferior to common iliac lesions.
However, 11 of 12 external iliac artery stenoses in our series
had to be stented versus five of 29 common iliac artery
stenoses, which may explain this difference. Recently, Lee et
al29 reported that the patency rates for external iliac and
common iliac stents appear to be similar.29
There has been some debate over whether FFB graft-
ing or IBA should be performed first when the procedures
are performed at the same setting. Proponents of the per-
formance of FFB grafting and IBA procedures simultane-
ously report decreased septic complications that are
associated with graft implantation in a previously punc-
tured site, decreased cost (approximately $1580.00 per
case in our series), and no need to interrupt anticoagula-
tion or antiplatelet therapy.10 Melliere et al10 also recom-
mend performing IBA after FFB grafting when the
procedures were performed at the same setting to avoid
clamping a recently dilated iliac artery. They felt that inter-
rupting flow in the recently dilated artery would risk
occlusion. Another idea that lends support to the perfor-
mance of the two procedures at the same setting is that, by
improving outflow with the bypass graft, there is a protec-
tive effect exerted on the angioplasty site.12,15 This is due
to the increased velocity through the iliac system after dis-
tal bypass grafting.
Those who favor successive procedures argue that
angioplasty can often be performed at the initial
angiogram. It is also felt by some that the success of angio-
plasty is increased in the better-equipped angiography
suite. Separation of the two procedures may also allow
time to identify those patients who experience early com-
plications or who had inadequate dilation before the distal
bypass grafting.13,14
Despite the advantages of combined FFB grafting and
IBA procedures, 5-year patency rates remain considerably
less than those for aortobifemoral bypass grafting. A sub-
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Table VI. Kaplan-Meier life table analysis of time to loss of secondary patency
Time At risk at start Treatment Withdrawn Interval Cumulative SE
interval (mo) of interval failure (n) (n) success success (%) (%)
Group A
0 28 0 0 1 100.00 0.00
1 28 0 0 1 100.00 0.00
12 28 0 1 1 100.00 0.00
18 27 0 0 1 100.00 0.00
24 27 1 3 0.962963 96.30 3.57
30 23 1 3 0.956522 92.11 5.40
36 19 1 4 0.947368 87.26 7.15
42 14 1 2 0.928571 81.03 9.43
48 11 0 1 1 81.03 10.64
54 10 0 4 1 81.03 11.16
60 6 0 2 1 81.03 14.41
66 4 0 4 1 81.03 17.65
Group B
0 13 0 0 1 100.00 0.00
1 13 5 0 0.615385 61.54 10.58
12 8 0 0 1 61.54 13.49
18 8 1 2 0.875 53.85 12.93
24 5 0 1 1 53.85 16.36
30 4 0 2 1 53.85 18.29
36 2 1 1 0.5 26.92 16.27
42 0 0 0
48 0 0 0
54 0 0 0
60 0 0 0
66 0 0 0
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stantial number of early failures may be related to the
length of the lesion. We reviewed all combined FFB graft-
ing and IBA procedures that were performed by a single
surgeon at our institution from 1991 through 1998. The
patient population was divided according to location and
length of the donor iliac lesion (group A, ≤5 cm; group B,
>5 cm). Group B had lower early successes and lower pri-
mary patency and secondary patency rates than group A.
More importantly, it should be noted that more than half
of the group B patients required revision of a procedure
within 30 days, as compared with zero revisions in group
A. It is on this basis that consideration should be given to
the performance of an aortofemoral or axillobifemoral
bypass grafting in these patients (according to their risk,
despite the increased morbidity) because repeated attempts
at extra-anatomic bypass grafting and repeated revision
may be more detrimental to the patient than aorto-
bifemoral bypass or axillobifemoral bypass grafting alone.
In conclusion, combined use of IBA and FFB proce-
dures is effective and durable, and the procedures can be
performed simultaneously if the donor iliac stenosis length
is 5 cm or less. PTA and stenting of stenoses of more than
5 cm fail to support FFB grafting in most patients; there-
fore, the combination of procedures should be ques-
tioned.
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